Financial Performance - Consolidated net sales for Q1 2024 were 10.8 million, or 19.6%, compared to Q1 2023[88] - Consolidated gross profit increased 72.4% to 1.5 million, or 2.7% of sales in Q1 2023[88] - Consolidated operating loss for Q1 2024 was 6.4 million in Q1 2023[89] - Adjusted EBITDA for Q1 2024 was (3.735) million, or (6.8)% of sales in Q1 2023[95] Segment Performance - Specialty Chemicals segment net sales decreased by 20.3 million in Q1 2024[90] - Tubular Products segment net sales totaled 7.2 million, or 23.3%, from Q1 2023[92] Cash Flow and Liquidity - Cash flows from operating activities decreased due to changes in working capital, with inventory increasing cash flows by 9.5 million in Q1 2023[103] - Accounts payable contributed 6.8 million in Q1 2023, indicating a decrease in inventory purchases[103] - Net cash used in investing activities decreased due to lower capital expenditures in Q1 2024 compared to Q1 2023[104] - The company had no outstanding debt as of March 31, 2024, and December 31, 2023, reflecting a decrease in cash used in financing activities[105][107] - The current ratio decreased from 3.7 as of December 31, 2023, to 3.2 as of March 31, 2024, indicating a decline in liquidity[111] Shareholder Actions - The company repurchased 16,330 shares at an average price of 163,221 in Q1 2024, compared to 32,313 shares at 327,521 in Q1 2023[108][109] Tax and Interest - Interest expense decreased to 1.1 million in Q1 2023 due to lower outstanding debt[94] - The effective tax rate for continuing operations was 22.3% for Q1 2024, lower than the U.S. statutory rate of 21.0%[94] Asset Management - The company incurred asset impairment charges of 32.1 million, with 6.2 million for the remainder of fiscal 2024[113] Equity and Debt Ratios - The debt to capital ratio remained at 0% as of March 31, 2024, consistent with no outstanding debt[111] - Return on average equity improved from -38.6% as of December 31, 2023, to -4.9% as of March 31, 2024, suggesting a reduction in losses[111]
Ascent Industries (ACNT) - 2024 Q1 - Quarterly Report